ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41002392

FGFR1 Inhibition by Pemigatinib Enhances Radiosensitivity in Glioblastoma Stem Cells Through S100A4 Downregulation.

Gouazé-Andersson V and 5 others. Cells, 2025. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. FGFR1 Inhibition by Pemigatinib Enhances Radiosensitivity in Glioblastoma Stem Cells Through S100A4 Downregulation. Papers, record 41002392. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41002392

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FGFR1 Inhibition by Pemigatinib Enhances Radiosensitivity in Glioblastoma Stem Cells Through S100A4 Downregulation.
PubMed
Journal
Cells
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-09-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gouazé-Andersson VValériehttps://orcid.org/0000-0002-1797-515X
2Delmas CCarolinehttps://orcid.org/0000-0001-5165-3608
3Nicaise YYvanhttps://orcid.org/0009-0001-2277-9583
4Nicolau JJulien
5Cerapio JPJuan Pablohttps://orcid.org/0000-0002-3032-3180
6Cohen-Jonathan Moyal EElizabeth

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
Neoplastic Stem CellsMajor topic
Radiation ToleranceMajor topic
S100 Calcium-Binding Protein A4Major topic
Receptor, Fibroblast Growth Factor, Type 1Major topic
Down-RegulationMajor topic
Brain NeoplasmsMajor topic
MorpholinesMajor topic
PyrimidinesMajor topic
Humans
Animals
Cell Line, Tumor
Mice
Xenograft Model Antitumor Assays
Mice, Nude
Signal Transduction
Gene Expression Regulation, Neoplastic

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
EU-FR-ST-20126 EU-FR-ST-20001Incyte (United States)PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,122,245Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma.Cell Rep2017https://conductscience.org/library/papers/28122245PubMed
232,315,352INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models.PLoS One2020https://conductscience.org/library/papers/32315352PubMed
330,894,200Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.J Transl Med2019https://conductscience.org/library/papers/30894200PubMed
429,316,430Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.Cancer Cell2018https://conductscience.org/library/papers/29316430PubMed
530,710,284The Multifaceted S100A4 Protein in Cancer and Inflammation.Methods Mol Biol2019https://conductscience.org/library/papers/30710284PubMed
630,909,436Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and Stemness.Cancers (Basel)2019https://conductscience.org/library/papers/30909436PubMed
738,838,500An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.ESMO Open2024https://conductscience.org/library/papers/38838500PubMed
835,420,673EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.Cancer Discov2022https://conductscience.org/library/papers/35420673PubMed
929,260,225Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.JAMA2017https://conductscience.org/library/papers/29260225PubMed
1032,805,233S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma.Am J Pathol2020https://conductscience.org/library/papers/32805233PubMed

1 to 10 of 43

See all 43 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42,415,204CD13 identifies S100A4+ immunosuppressive monocytes and predicts temozolomide benefit in glioblastoma.Biol Direct2026https://conductscience.org/library/papers/42415204

Source PubMed

Genes41

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
ANXA2302PubTator's text mininghttps://conductscience.org/library/genes/302NCBI Gene
CETN11,068PubTator's text mininghttps://conductscience.org/library/genes/1068NCBI Gene
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EPHB22,048PubTator's text mininghttps://conductscience.org/library/genes/2048NCBI Gene
FGF112,256PubTator's text mininghttps://conductscience.org/library/genes/2256NCBI Gene
FGF22,247PubTator's text mininghttps://conductscience.org/library/genes/2247NCBI Gene
FGFR12,260PubTator's text mininghttps://conductscience.org/library/genes/2260NCBI Gene
FGFR22,263PubTator's text mininghttps://conductscience.org/library/genes/2263NCBI Gene

1 to 10 of 41

See all 41 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41002392

GET https://conductscience.org/api/papers/v1/41002392/references?page=2

API referenceFor AI assistants